These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9179431)

  • 1. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.
    Genovese A; Patella V; De Crescenzo G; De Paulis A; Spadaro G; Marone G
    Clin Exp Allergy; 1997 May; 27(5):559-67. PubMed ID: 9179431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
    Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
    Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs.
    Marone G; Stellato C; Mastronardi P; Mazzarella B
    Ann Fr Anesth Reanim; 1993; 12(2):116-25. PubMed ID: 7690200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.
    Patella V; Bouvet JP; Marone G
    J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
    Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
    J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
    Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
    Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous effects of protamine on human mast cells and basophils.
    Patella V; Ciccarelli A; Lamparter-Schummert B; de Paulis A; Adt M; Marone G
    Br J Anaesth; 1997 Jun; 78(6):724-30. PubMed ID: 9215027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human heart mast cells: a definitive case of mast cell heterogeneity.
    Patella V; de Crescenzo G; Ciccarelli A; Marinò I; Adt M; Marone G
    Int Arch Allergy Immunol; 1995 Apr; 106(4):386-93. PubMed ID: 7536502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization.
    de Paulis A; Marinò I; Ciccarelli A; de Crescenzo G; Concardi M; Verga L; Arbustini E; Marone G
    Arthritis Rheum; 1996 Jul; 39(7):1222-33. PubMed ID: 8670335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
    de Paulis A; Ciccarelli A; Marinò I; de Crescenzo G; Marinò D; Marone G
    Arthritis Rheum; 1997 Mar; 40(3):469-78. PubMed ID: 9082935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release.
    Stellato C; de Crescenzo G; Patella V; Mastronardi P; Mazzarella B; Marone G
    J Allergy Clin Immunol; 1996 Mar; 97(3):838-50. PubMed ID: 8613641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antihistamines on inflammatory mediators.
    Naclerio RM
    Ann Allergy; 1993 Sep; 71(3):292-5. PubMed ID: 7690526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
    de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
    J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients.
    Horak F; Toth J; Hirschwehr R; Marks B; Stübner UP; Jäger S; Berger U; Schleinzer K; Günczler P
    Allergy; 1998 Jan; 53(1):68-72. PubMed ID: 9491231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.
    Niimi N; Francis DM; Kermani F; O'Donnell BF; Hide M; Kobza-Black A; Winkelmann RK; Greaves MW; Barr RM
    J Invest Dermatol; 1996 May; 106(5):1001-6. PubMed ID: 8618029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue.
    Genovese A; Stellato C; Patella V; Lamparter-Schummert B; de Crescenzo G; Adt M; Marone G
    Int J Clin Lab Res; 1996; 26(3):192-8. PubMed ID: 8905451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction.
    Xia HZ; Kepley CL; Sakai K; Chelliah J; Irani AM; Schwartz LB
    J Immunol; 1995 May; 154(10):5472-80. PubMed ID: 7730649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI.
    Okayama Y; Hagaman DD; Metcalfe DD
    J Immunol; 2001 Apr; 166(7):4705-12. PubMed ID: 11254731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.